Measles virus (MV) is a human pathogen using two distinct cell surface receptors for entry into host cells. We present here a comparative analysis for binding of the MV receptors CD46 and SLAM to the virus hemagglutinin protein (MVH, Edmonston). 
Abstract.
Measles virus (MV) is a human pathogen using two distinct cell surface receptors for entry into host cells. We present here a comparative analysis for binding of the MV receptors CD46 and SLAM to the virus hemagglutinin protein (MVH, Edmonston).
Soluble monomeric and dimeric MVH variants were prepared in mammalian cells and their conformation assessed using a panel of monoclonal antibodies. The two receptor molecules specifically bound to the MVH protein with distinct binding modes. The association rate (kass) for SLAM binding to MVH was very low (~3000 M 
Introduction.
A large variety of cell surface receptors are used by viruses for entry into cells.
Even though there is specificity in virus-receptor recognition, flexibility in receptor usage has been reported for several enveloped and non-enveloped viruses (1) . Virus strains differing in the cellular receptor used for attachment and entry appear during the course of the infection. A well documented example is provided by measles virus (MV) (2) (3) (4) (5) (6) (7) (8) (9) , which can use cell surface receptor molecules from two distinct families, CD46
(membrane cofactor protein) and SLAM (signaling lymphocyte-activation molecule, CDw150).
MV is a highly contagious agent infecting millions of individuals worldwide, and one of the most serious diseases in children in developing countries, causing more than one million deaths annually (10) . The virus belongs to the Morbillivirus genus of the Paramyxovirus family (11) . The virus particle contains a negative strand RNA genome packed in a ribonucleoprotein structure, surrounded by an envelope or lipid bilayer with two transmembrane glycoproteins, the hemagglutinin (MVH) and the fusion protein (MVF). MVH is a type II membrane protein that forms disulfide-linked homodimers on the surface of the virus. The extracellular region of the protein has been predicted to fold into a C-terminal β-propeller domain connected by a protein stalk to the membrane spanning domain, as described for related proteins of members of the Paramyxovirus family (12,13). MVF is a type I membrane protein formed by two disulfide linked polypeptides (F1 and F2) in its mature conformation (11) . It is expected to form tetramers at the virus membrane and associate with the MVH dimers. The precise nature 4 of these interactions and the processes linking receptor binding to membrane fusion are currently unknown.
Characterized strains or isolates of MV differ in their cellular tropism (4-7).
These differences appear to be related to differences in cellular receptor recognition for cell entry. The ubiquitously expressed CD46 was first characterized as the receptor for the vaccine or Edmonston strain of MV (2,3). The CD46 ectodomain contains 4 short consensus repeats domains (SCR1-SCR4), and the two N-terminal repeats bind to MV.
The structure of the MV binding fragment of CD46 revealed a large binding surface, with a central protruding loop bearing a critical virus binding residue (14) . MV strains differ in their affinity for CD46 (8) . While virus variants grown in fibroblast-like cells bind well to CD46 on the cell surface, primary isolates or viruses grown in lymphoid cells have low affinity or undetectable binding to this receptor. These differences correlate with a single Asn to Tyr mutation in the MVH glycoprotein (7, 8) . Recently, the lymphocyte-specific receptor molecule SLAM was identified as a receptor for MV (9) .
Primary isolates, lymphotropic and laboratory adapted virus variants all bound to SLAM on the cell surface with comparable affinity (9, 15) . These data suggests that SLAM could be the primary receptor during measles virus infections and that new virus species with increased affinity for the ubiquitous CD46 receptor could arise during the course of the infection, facilitating spreading of the virus throughout the body. Moreover, primary infection of lymphocytes by the virus may explain the immune-suppression associated with MV infections (9) . (CD46/SCR3-4) was expressed in Pichia Pastoris using the expression vector pPICZAα (Invitrogen). The CD46/SCR3-4 protein contains residues 159 to 285 of the precursor CD46 polypeptide, followed by six-His residues at its C-terminal end. Yeast clones secreting the protein to the supernatant were selected with zeocine as recommended by manufacturer (Invitrogen). Protein was purified from yeast supernatants by chelate affinity chromatography (Pharmacia). All the proteins were subjected to size exclusion chromatography as a final purification step for removal of high molecular aggregates.
Purity was checked by PAGE and the concentration calculated from the protein extinction coefficient, determined from their amino acid composition.
Soluble SLAM. A full length SLAM cDNA was generated by RT-PCR from total RNA isolated from JY cells using specific primers and subcloned into the unique EcoRI 
Immunoprecipitation of soluble MVH variants.
293T cells (2. 
Binding of soluble CD46, SLAM and antibodies to MVH in BIAcore.
Surface plasmon resonance was applied to monitor protein-protein interactions using a BIAcore 2000 instrument and CM5 sensor chips. HEPES-buffer (10mM Hepes, 150mM NaCl, pH 7.5) was used as running buffer. First, the anti-HA antibody was covalently immobilized in the dextran surface of the chip via primary amino groups using the amine coupling kit (BIAcore). Anti-HA (30 ng/ml) was injected in 10 mM sodium acetate, pH 5. Kinetic rates determined at four different temperatures were used to calculate the activation energy of the association and dissociation reactions as described (16) .
Enthalpy (∆H 0 ) was determined from the differences between activation energy for association and dissociation reactions.
Results.
Expression of soluble measles virus hemagglutin (MVH) proteins.
The MVH glycoprotein has the transmembrane domain at its N-terminal end, so that the expression of soluble MVH variants required replacement of the cytoplasmic and transmembrane domains by the murine Igκ chain leader sequence (Fig. 1A) . Several constructs having different fragments of the extracellular region of the protein were prepared using the Cys residues as reference. The conformation of the MVH soluble variants was assessed using a panel of monoclonal antibodies recognizing four different antigenic sites previously defined in the MVH protein (21) . Monoclonal antibodies representing all four antigenic sites immunoprecipitated the six expressed soluble variants of the Edmonston strain of MV (Fig. 2) . Differences in the amount of protein among the different variants could be related to differences in protein expression.
Receptor binding to soluble MVH.
Soluble protein fragments of CD46 having the two N-terminal short consensus repeats (CD46/SCR1-2) or the four SCR of the protein (CD46/SCR1-4) were prepared in CHO-Lec cells and presented a low glycosylation-related heterogeneity (Fig. 3A, inset) .
A BIAcore 2000 instrument was used to monitor CD46 binding to soluble MVH. The MVH protein carrying a HA epitope at the N-terminus (Fig. 1) were captured on surfaces having covalently immobilized anti-HA antibody (Fig. 3A) . CD46 was subsequently injected through surfaces having or lacking captured MVH protein, and the increase in the baseline after CD46 injection (buffer 2, Fig. 3A ) was recorded specifically in the surfaces having MVH protein. Binding was specific for soluble CD46 receptors with SCR1-2 and SCR1-4 (Fig. 3B ). About two times higher binding (RU) for CD46/SCR1-4 than CD46/SCR1-2 was monitored at the end of the receptor injection. This was consistent with the differences in size between the two proteins, and suggested similar binding affinities. The CD46/SCR3-4 protein lacking the MV binding site did not bind to the sensor chip surface with captured MVH (Fig. 3B) .
The complete extracellular region of the SLAM receptor (SLAM) was also expressed in mammalian cells and purified for analysis of binding to MVH in BIAcore (Fig. 4) . The size of the soluble receptor was as expected (Fig. 4, inset) and it bound to the monoclonal antibody IPO-3 after final purification. SLAM bound specifically to BIAcore surfaces having captured MVH protein (Fig. 4) . However the binding sensorgrams were strikingly different from those recorded during the injection of CD46 (Fig. 5 ).
Affinity and kinetics for binding of monomeric soluble receptor to MVH.
Determination of the kinetics for receptor binding to MVH required recording of several cycles of receptor association and dissociation using different receptor concentrations (Fig. 5) . Binding of the receptor to the surface with immobilized MVH increased with the receptor concentration. About 10 times higher concentration of SLAM receptor than CD46 was required to have similar binding. However, the CD46 protein dissociated faster from MVH than SLAM. Sensorgrams recorded for CD46
plateau, indicating higher binding kinetic rates for CD46 than for SLAM.
Kinetic and affinity constants were first determined from the recorded binding sensorgrams at 25 o C (Table I) (Table II) .
Overlapping CD46 and SLAM binding sites in MVH.
A receptor binding competition experiment was carried out with plastic coated MVH protein, monomeric soluble CD46 molecules and a dimeric SLAM-Fc protein ( show that neutralizing antibodies prevent receptor binding.
Discussion.
We have analyzed virus-receptor interactions with soluble MVH proteins and the two receptor molecules used by MV for entry into host cells. The soluble variants used here were recognized by monoclonal antibodies directed to four MVH antigenic sites (21) and therefore they must have the same conformation as the protein present in the virus envelope. Our data revealed that the CD46 and SLAM receptors bind to overlapping but distinct interacting surfaces in MVH, as shown by the large differences in their binding kinetics. Binding kinetics provide information on the nature of protein-protein interactions. The rate of association is dependent on the rate of diffusion, and can be modulated by electrostatic forces (27) . On the other hand, the rate of dissociation can be directly correlated with the strength of the binding interaction. High kinetic rates arise from electrostatic protein-protein interactions, while relatively hydrophobic binding surfaces result in lower rates (28) .
The kinetic rates determined for the binding of the SLAM receptor to the MVH protein (Table I) Binding of both receptor molecules to MVH was exothermic, as that described for binding of CD4 to the HIV gp120 protein (19) . We would expect that the energy released µl/min using HEPES-buffer (pH 7.5) with 150 mM NaCl as running buffer. Affinity constants (K D ) at four different temperatures (10-30°C) were determined from the kinetic rate constants as in Table I . Average for 3-4 experiments for each temperature is shown, with standard deviations in parentheses. Experiments were done as in Table I .
Enthalpies (∆H°) for the interactions were determined from the difference between the activation energy for the association and dissociation, as described in Methods. 
